Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Comment by alphatradron Apr 12, 2019 5:00pm
132 Views
Post# 29621115

RE:Time to average down

RE:Time to average downAverage down? Funny.  This stock is not worth paying a dollar, yet, but at all.  A dollar is way overvalued presently.  Remember it was pennies?  Hello...  When at around .60 it flew up for a reason, it was the right value.  Maybe you're new to this stock history...  This stock needs to earn it.  We need few road tests.  How many times have they changed names?  And now after 1:45 a new name?  It means nothing.  Let's make money tho.  You will not get 50% hikes at a dollar.  It will go back down, of course.  Around 50% profits, selling is the smartest.  The ones who didn't will regret, simply.  This stock will not sky rock like it's Canopy.  Who are you kidding. 
Bullboard Posts